Clonidine
- Product NDC
- 52817-375
- 11-digit product format
- 528170375
- Labeler code
- 52817
- Product ID
- 52817-375_0eb6d1fe-949a-312a-e063-6294a90ae10c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clonidine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- TruPharma, LLC
- Application
- NDA022500
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2024-01-11
- Substance
- CLONIDINE
- Active strength
- .17 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022500-001 | NEXICLON XR | CLONIDINE | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | ||
| N022500-002 | NEXICLON XR | CLONIDINE | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | |
| N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | |
| N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | |
| N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022500-001 | CLONIDINE | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022500-002 | CLONIDINE | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N022500-001 | NEXICLON XR | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N022500-002 | NEXICLON XR | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2009-12-03 | bb7c543d1eb4… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022500-001 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022500-001 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022500-002 | 8337890 | 2027-04-17 | Drug product | 2020-07-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022500-002 | 8623409 | 2031-09-08 | Drug product | 2020-07-01 | d8e5a09893c0… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clonidine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CLONIDINE | .17 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| MN3L5RMN02 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 885880 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2311836b-de63-4e8c-a021-600c40110024 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 45c8ba14-e378-46f0-b21f-1aad8e08c613 | Product name | 1 | 20250221 |
| 6920b0ed-30bc-b127-73e1-0713049bd41e | Product name | 9 | 20190618 |
| a90f088a-9578-47a2-8f6e-0a9d32aafec6 | Product name | 1 | 20181030 |
| f6c90bdc-1674-455a-aadd-1b1b59e5edeb | Product name | 2 | 20181030 |
| 6920b0ed-30bc-b127-73e1-0713049bd41e | Product name | 5 | 20171212 |
| 48f5a4fd-7cdc-dc04-771d-ce7a47326789 | Product name | 2 | 20150123 |
| 624cf764-e200-44b5-83c2-84526255adb5 | Product name | 1 | 20150107 |
| 47972e1b-c905-eeee-5e77-eb4538ad833c | Product name | 1 | 20140508 |
| 7667d8e2-e5be-36e1-4de7-231aa7fdaf5c | Product name | 1 | 20140508 |
| f1ec5c2f-d01e-a277-5826-c7eba86ed99b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52817-375-30 | Clonidine | 30 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 30 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52817-375-30 | EA - Each | 52817-375 | 34f5d8cc-3974-41c5-b150-6cd474736f74 | 1 | 2024-02-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nexiclon XR | CLONIDINE | Rosemont Pharmaceuticals LLC | dad35a6f-d57e-f302-e053-2995a90a9efb | 2026-04-15 | Warnings, Adverse reactions | 022500 NDA022500 |
| Clonidine | CLONIDINE | TruPharma, LLC | 2311836b-de63-4e8c-a021-600c40110024 | 2024-01-11 | Warnings, Adverse reactions | 022500 NDA022500 52817-375 |
| Clonidine | CLONIDINE | PALMETTO PHARMACEUTICALS INC. | e93324f1-ad83-7bbe-e053-2995a90a8c9e | 2024-01-11 | Warnings, Adverse reactions | 022500 NDA022500 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 885880 | cloNIDine 0.17 MG 24HR Extended Release Oral Tablet | PSN | 2311836b-de63-4e8c-a021-600c40110024 | 1 |
| 885880 | 24 HR clonidine 0.17 MG Extended Release Oral Tablet | SCD | 2311836b-de63-4e8c-a021-600c40110024 | 1 |
| 885880 | clonidine 0.17 MG (equivalent to clonidine HCl 0.2 MG) 24 HR Extended Release Oral Tablet | SY | 2311836b-de63-4e8c-a021-600c40110024 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 52817-375-30 | 52817037530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52817-375-30) | 2024-01-11 | No | No | Current |